Drug discovery investors
6 investors that name Drug discovery among their sectors are recorded here, among them 2 venture capital firms, 1 accelerator, 1 corporate venture arm and 1 investor. Stated investment stages run from pre-seed to Series B. Most are headquartered in the United States (3), Switzerland (1) and the United Kingdom (1). Every fact comes from the investor’s own website and links back to the page it was read from. Coverage is incomplete and biased toward investors who publish clearly.
| Investor | Layer | Type | Stage | Headquarters |
|---|---|---|---|---|
| Advent Life Sciences LLP Life Sciences · drug discovery · med tech · enabling technologies |
Direct investor | Venture capital | Seed – Series B | London, United Kingdom |
| AION Labs AI · pharma · drug discovery · drug development |
Direct investor | Venture studio | Pre-seed – Seed | Rehovot, Israel |
| Astellas Venture Management biotechnology · therapeutics · platform technologies · drug discovery |
Direct investor | Corporate venture | Pre-seed – Series A | South San Francisco, United States |
| BaseLaunch biotech · therapeutics · oncology · immunology |
Direct investor | Accelerator | Pre-seed – Series A | Basel, Switzerland |
| Care Equity Capital Management, L.P. drug discovery · drug development services · biopharmaceutical |
Direct investor | Other | Unknown | New York, United States |
| Cure Ventures Management, LP life sciences · biotech · drug discovery · therapeutics |
Direct investor | Venture capital | Seed – Series A | Boston, United States |